Schedule 13D ownership disclosure
Akebia Therapeutics Inc
Security class unavailable · CUSIP: 00972D105
Event date: 2017-07-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.4800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-228620
- Form type
- SC 13D
- Filer
- Akebia Therapeutics, Inc.
- CIK
- CIK 1517022
- Filed
- Jul 14, 2017
- Reporting period
- Jul 05, 2017
- Description
- Schedule 13D beneficial ownership